Screening for Hepatitis C Using a Rapid Diagnostic Orientation Test (TROD) in Patients Over 50 Years Old in the Digestive Endoscopy Department of the Europeen Hospital Marseille
TROCENDO
1 other identifier
observational
5,000
1 country
1
Brief Summary
Chronic viral hepatitis C is a public health problem and several management recommendations are available. According to the French High Authority of Health, hepatitis C screening consists of a targeted screening of people at risk of infection by the virus, in particular drug users, people from countries with a high prevalence of the virus or who have received care in those countries, people transfused before 1992, or people who are or have beenincarcerated . French government recommendations aim to achieve elimination of hepatitis C virus HCV (as early as 2025) and since April 2018 the European Hospital Marseille is engaged in this battle and organizes every year "the day without hepatitis" in the hospital. Since 2017, direct-acting antiviral treatments have become available in France to all patients infected with HCV, regardless of the degree of severity of their disease. These treatments are effective in more than 95% of cases and, in 2019, 18,000 people were cured. As of today, it is estimated that there are still 110,000 people likely to be treated in France. Among them, 75,000 are unaware of being HCV positive, people who need to be tested. With one of the largest volumes of digestive endoscopic examinations in France, the European Hospital Marseille may be a significant source of screening for hepatitis C. Our study proposes to evaluate hepatitis C screening in consenting patients hospitalized in the endoscopy department at the European Hospital Marseille.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2021
CompletedFirst Posted
Study publicly available on registry
November 2, 2021
CompletedStudy Start
First participant enrolled
January 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFebruary 10, 2022
October 1, 2021
1.1 years
October 21, 2021
February 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients aged 50 and over tested positive for chronic viral hepatitis C during gastrointestinal endoscopy.
16 months
Secondary Outcomes (3)
Number of patients who refuse viral screening
16 months
Investigation and identification of potential risk factors in patients diagnosed positive for chronic viral hepatitis C
16 months
Number of viremic patients without risk factor
16 months
Study Arms (1)
Experimental
Patient undergoing digestive endoscopy and aged 50 years and over
Interventions
Inclusion of patients during the consultation with the gastroenterologist, before hospitalization in the digestive endoscopy department. Each consenting patient benefits from a HCV screening using TROD on the day of their hospitalization in the department.
Eligibility Criteria
Patients aged 50 and over hospitalized in the digestive endoscopy department
You may qualify if:
- Aged ≥ 50
- Giving free and informed written consent
- Being affiliated with or benefiting from a social security scheme
You may not qualify if:
- \- Patient unable to express consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Européen Marseille
Marseille, 13003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2021
First Posted
November 2, 2021
Study Start
January 24, 2022
Primary Completion
March 1, 2023
Study Completion
September 1, 2023
Last Updated
February 10, 2022
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share